The Pentagon announces plans to provide testosterone treatment to US service members, according to reporting by the Financial Times (US and World editions). The move is attributed to Defence Secretary Pete Hegseth. The announcement comes amid broader public and political discussion in the United States about male reproductive health, including concerns about low sperm counts and sexual or physical “virility.”
Details of eligibility, medical oversight, and how the treatment will be administered are not specified in the provided summaries. The reports frame the decision as part of the Pentagon’s response to perceived concerns about troop strength and related health outcomes. The initiative reflects ongoing debates about how military health services should address fertility and hormones, as well as how such topics are discussed in political contexts.
Overall, the available information centers on the Pentagon’s stated intention to offer testosterone therapy to troops, alongside the public discourse that prompted or accompanied the announcement.
